Switzerland clinical trials market is projected to grow by 6.8% annually in the forecast period and reach $824.5 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 80 tables and 70 figures, this 170-page report "Switzerland Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Switzerland clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Switzerland market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Switzerland clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Region.
Based on Product Category, the Switzerland market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
• Trials of Devices
• Trials of Procedures
Based on Phase, the Switzerland market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Phase I
• Phase II
• Phase III
• Phase IV
By Design, the Switzerland market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
• Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
• Expanded Access Trials
By Service Type, the Switzerland market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services
By Indication, the Switzerland market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications
By End User, the Switzerland market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Aargau [Argovia]
• Appenzell Outer Rhodes
• Appenzell Inner Rhodes
• Basel-Landschaft
• Basel-Stadt [Basel-City]
• Bern
• Fribourg
• Genève [Geneva]
• Glarus
• Graubünden [Grisons]
• Jura
• Luzern
• Neuchâtel
• Nidwalden [Nidwald]
• Obwalden [Obwald]
• Schaffhausen
• Schwyz
• Solothurn
• St. Gallen
• Thurgau [Thurgovia]
• Ticino
• Uri
• Valais
• Vaud
• Zug
• Zürich [Zurich]
For each key region, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PhlexSwitzerland
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 28
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porter's Fiver Forces Analysis 46
3 Segmentation of Switzerland Market by Product Category 50
3.1 Market Overview by Product Category 50
3.2 Trials of Drugs 52
3.2.1 Small Molecule Drugs 53
3.2.2 Vaccines 54
3.2.3 Cell & Gene Therapy 55
3.2.4 Other Drugs 56
3.3 Trials of Devices 57
3.4 Trials of Procedures 58
4 Segmentation of Switzerland Market by Phase 59
4.1 Market Overview by Phase 59
4.2 Phase I 61
4.3 Phase II 62
4.4 Phase III 63
4.5 Phase IV 64
5 Segmentation of Switzerland Market by Design 65
5.1 Market Overview by Design 65
5.2 Interventional Studies 67
5.2.1 Randomized Control Trial 69
5.2.2 Adaptive Clinical Trial 70
5.2.3 Non-randomized Control Trial 71
5.3 Observational Studies 72
5.3.1 Cohort Study 74
5.3.2 Case Control Study 75
5.3.3 Cross Sectional Study 76
5.3.4 Ecological Study 77
5.4 Expanded Access Trials 78
6 Segmentation of Switzerland Market by Service Type 79
6.1 Market Overview by Service Type 79
6.2 Protocol Designing 81
6.3 Site Identification 82
6.4 Patient Recruitment 83
6.5 Laboratory Services 84
6.6 Bioanalytical Testing Services 85
6.7 Clinical Trial Data Management Services 86
6.8 Clinical Trial Supply & Logistic Services 87
6.9 Decentralized Clinical Trial Services 88
6.10 Medical Device Testing Services 89
6.11 Other Clinical Trial Services 90
7 Segmentation of Switzerland Market by Indication 91
7.1 Market Overview by Indication 91
7.2 Oncology 93
7.3 Infectious Diseases 95
7.4 Cardiology 96
7.5 Obesity 97
7.6 Diabetes 98
7.7 Neurology 99
7.8 Immunology 100
7.9 Pain Management 101
7.10 Other Indications 102
8 Segmentation of Switzerland Market by End User 103
8.1 Market Overview by End User 103
8.2 Pharmaceutical and Biotechnological Companies 105
8.3 Clinical Research Organizations 106
8.4 Clinical Testing Laboratories 107
8.5 Other End Users 108
9 Segmentation of Switzerland Market by Region 109
10 Competitive Landscape 111
10.1 Overview of Key Vendors 111
10.2 New Product Launch, Partnership, Investment, and M&A 114
10.3 Company Profiles 115
Accell Clinical Research LLC 115
Charles River Laboratories 117
ClinDatrix Inc 120
Clinipace 121
Eli Lilly and Company 123
F. Hoffmann-La Roche Ltd. 126
ICON PLC 129
IQVIA Holdings, Inc. 132
Laboratory Corporation of America (Covance Inc.) 136
Novo Nordisk AS 140
PAREXEL International Corporation 143
Pfizer Inc. 147
Pharmaceutical Product Development LLC 152
Phlexglobal 155
PRA Health Sciences 157
Sanofi SA 159
SGS SA (SGS Life Sciences) 162
Syneos Health Inc. 165
Wuxi AppTec Inc. 168
RELATED REPORTS 170
The Digital Pathology Image Analysis Software for Clinical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, com...
The Decentralized & Digitalized Clinical Trials Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Clinical Trial Temperature Control Logistics Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...
The Clinical Trial Drug Sourcing Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Clinical Trial Logistics Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Clinical Trial Adjudication Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Clinical Trial Simulation Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cloud Computing in Clinical Trials Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Clinical Database Management Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Clinical Trial Management Organizations Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...